Research Grants Program

Perhaps nowhere else in dermatology is so little known about a disorder that affects so many. Because the cause of rosacea is unknown and there is no cure, the National Rosacea Society's research grants program was established to encourage and support research into the potential causes and other key aspects of this condition that may lead to improvements in its treatment and potential prevention or cure. The program is supported by donations from individuals, and funds are available to researchers worldwide.

Help win the fight against rosacea today. To apply for a research grant, click here. To learn more about donating to this important program, click here.

Medical Advisory Board

Grant applications are reviewed and selected for funding by the Society's medical advisory board, which is chaired by the former Director of Dermatologic and Dental Drug Products at the U.S. Food and Drug Administration and includes three former presidents of the American Academy of Dermatology (AAD).

Dr. Mark Dahl, Chairman Professor Emeritus The Mayo Clinic College of Medicine (former AAD president)	Dr. Marian Macsai Professor of Ophthalmology University of Chicago
Dr. Michael Detmar Professor of Pharmacogenomics Federal Institute of Technology Zurich, Switzerland	Dr. David Norris Chairman of Dermatology University of Colorado (former SID president)
Dr. Lynn Drake Harvard Medical School (former AAD president)	Dr. Richard Odom Professor of Clinical Dermatology University of California - San Francisco (former AAD president)
Dr. Richard Gallo Chief, Division of Dermatology University of California - San Diego	Dr. Frank Powell Consultant Dermatologist Regional Centre of Dermatology Dublin, Ireland
Dr. Alexa Boer Kimball Director, Clinical Unit for Research Trials in Skin Harvard Medical School	Honorary Member Dr. Jonathan Wilkin Former Director, Dermatologic and Dental Drug Products Food and Drug Administration

Awarded Grants

Grants for 51 studies have been awarded to date, and have led to further investigations in such promising areas as the potential effects of vascular endothelial growth factor (VEGF), Demodex mites, the immune system and other inflammatory pathways, as well as a potential diagnostic test for ocular rosacea. A full listing of grants awarded to date can be found here.

Research Results

As studies funded by the National Rosacea Society are completed, reports on results are published on this site and in Rosacea Review. An archive of reports on research funded by the National Rosacea Society can be found here.

Classification of Rosacea

A standard classification system was developed and published by the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea to unify research, improve clinical diagnosis and provide common terminology for communications. It can be viewed online here.

Grading of Rosacea

A standard grading system for rosacea was published by the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea to unify research and improve clinical assessment. It can be viewed online here.